Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis.

Alexandra M Nanzer Jaideep DhariwalJoanne KavanaghAndrew HearnMariana FernandesLouise ThomsonCris RoxasLinda GreenGrainne D'AnconaSangita AgarwalBrian D Kent

Published in: ERJ open research (2020)

Benralizumab reduces oral corticosteroid requirements in patients with EGPA and leads to improved patient-reported outcome measures https://bit.ly/2GI0vhf.

Keyphrases

patient reported
robot assisted
chronic rhinosinusitis
minimally invasive